About Ixcela
Ixcela is a company based in Bedford (United States) founded in 2012. Ixcela has raised $7.99 million across 3 funding rounds. Ixcela offers products and services including Gut Health Test, Virtual Consultations, and Digital Evaluation Tool. Ixcela operates in a competitive market with competitors including Helix, Counsyl, Seed, Azitra and Microba, among others.
- Headquarter Bedford, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ixcela, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.99 M (USD)
in 3 rounds
-
Latest Funding Round
$3.82 M (USD), Series A
Oct 14, 2020
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ixcela
Ixcela offers a comprehensive portfolio of products and services, including Gut Health Test, Virtual Consultations, and Digital Evaluation Tool.
Proprietary at-home test for analyzing gut microbiome and providing personalized insights.
Personalized nutrition advice from dietitians for various health issues and symptoms.
Free AI-based survey for estimating gut health without proprietary testing.
People of Ixcela
Unlock access to complete
Unlock access to complete
Funding Insights of Ixcela
Ixcela has successfully raised a total of $7.99M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.82 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Ixcela
Investment portfolio details for Ixcela
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ixcela
Detailed financials for Ixcela
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ixcela Comparisons
Peer comparison for Ixcela
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ixcela
Ixcela operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Counsyl, Seed, Azitra and Microba, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
|
|
| Locked | Locked | Locked |
Synbiotics are developed for simulating the gut microbiome.
|
|
| Locked | Locked | Locked |
Microbiome-based therapeutics for skin conditions like eczema are developed.
|
|
| Locked | Locked | Locked |
Developer of microbiome-based drug discovery platform
|
|
| Locked | Locked | Locked |
Provider of direct-to-consumer genetic testing.
|
Detailed competitors of Ixcela
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ixcela
Complete news archive for Ixcela
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ixcela
Ixcela was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Ixcela is headquartered in Bedford, United States.
Ixcela is a funded company, having raised a total of $7.99M across 3 funding rounds to date.
Ixcela was founded in 2012 in Bedford, United States, within the health technology sector focused on microbiome analysis. An online platform is utilized to order gut microbiome test kits for periodic evaluation of microbiota health through key metabolite measurements. Personalized dietary supplements are developed based on these results to support gut microbiome balance. Operations center on direct-to-consumer testing and supplement formulation.
Ixcela offers Gut Health Test, Virtual Consultations, and Digital Evaluation Tool.